News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
579,851 Results
Type
Article (58954)
Company Profile (125)
Press Release (520772)
Multimedia
Podcasts (42)
Webinars (11)
Section
Business (160356)
Career Advice (1437)
Deals (25494)
Drug Delivery (81)
Drug Development (67084)
Employer Resources (104)
FDA (14287)
Job Trends (12688)
News (272555)
Policy (25885)
Tag
Academia (2835)
Academic (1)
Accelerated approval (5)
Adcomms (12)
Allergies (88)
Alliances (43929)
ALS (87)
Alzheimer's disease (1316)
Antibody-drug conjugate (ADC) (102)
Approvals (14319)
Artificial intelligence (258)
Autoimmune disease (18)
Automation (11)
Bankruptcy (200)
Best Places to Work (9773)
BIOSECURE Act (11)
Biosimilars (64)
Biotechnology (77)
Bladder cancer (72)
Brain cancer (26)
Breast cancer (259)
Cancer (2083)
Cardiovascular disease (155)
Career advice (1212)
Career pathing (25)
CAR-T (133)
Cell therapy (361)
Cervical cancer (19)
Clinical research (54111)
Collaboration (781)
Compensation (211)
Complete response letters (14)
COVID-19 (2433)
CRISPR (39)
C-suite (220)
Cystic fibrosis (82)
Data (2133)
Decentralized trials (2)
Denatured (22)
Depression (42)
Diabetes (222)
Diagnostics (5350)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (27)
Drug discovery (108)
Drug pricing (84)
Drug shortages (22)
Duchenne muscular dystrophy (79)
Earnings (59174)
Editorial (35)
Employer branding (16)
Employer resources (92)
Events (77718)
Executive appointments (641)
FDA (15548)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (655)
Gene editing (83)
Generative AI (22)
Gene therapy (253)
GLP-1 (617)
Government (3955)
Grass and pollen (6)
Guidances (146)
Healthcare (16466)
Huntington's disease (14)
IgA nephropathy (18)
Immunology and inflammation (77)
Indications (27)
Infectious disease (2551)
Inflammatory bowel disease (118)
Inflation Reduction Act (4)
Influenza (51)
Intellectual property (84)
Interviews (274)
IPO (11249)
IRA (33)
Job creations (3281)
Job search strategy (1049)
Kidney cancer (8)
Labor market (29)
Layoffs (350)
Leadership (10)
Legal (5115)
Liver cancer (70)
Lung cancer (295)
Lymphoma (138)
Machine learning (8)
Management (34)
Manufacturing (233)
MASH (69)
Medical device (13646)
Medtech (13650)
Mergers & acquisitions (14722)
Metabolic disorders (577)
Multiple sclerosis (73)
NASH (12)
Neurodegenerative disease (80)
Neuropsychiatric disorders (17)
Neuroscience (1814)
NextGen: Class of 2025 (5442)
Non-profit (4318)
Now hiring (29)
Obesity (281)
Opinion (170)
Ovarian cancer (77)
Pain (86)
Pancreatic cancer (72)
Parkinson's disease (139)
Partnered (21)
Patents (193)
Patient recruitment (106)
Peanut (46)
People (48376)
Pharmaceutical (31)
Pharmacy benefit managers (12)
Phase I (16580)
Phase II (23512)
Phase III (18177)
Pipeline (1243)
Policy (112)
Postmarket research (2376)
Preclinical (7680)
Press Release (66)
Prostate cancer (97)
Psychedelics (25)
Radiopharmaceuticals (227)
Rare diseases (295)
Real estate (5240)
Recruiting (37)
Regulatory (18677)
Reports (29)
Research institute (2566)
Resumes & cover letters (204)
Rett syndrome (5)
RNA editing (2)
RSV (33)
Schizophrenia (74)
Series A (107)
Series B (69)
Service/supplier (11)
Sickle cell disease (43)
Special edition (15)
Spinal muscular atrophy (137)
Sponsored (24)
Startups (3137)
Stomach cancer (9)
Supply chain (52)
Tariffs (30)
The Weekly (20)
Vaccines (624)
Venture capitalists (20)
Weight loss (184)
Women's health (24)
Worklife (10)
Date
Today (156)
Last 7 days (813)
Last 30 days (2514)
Last 365 days (26694)
2025 (9656)
2024 (28947)
2023 (33357)
2022 (44034)
2021 (47430)
2020 (45854)
2019 (39929)
2018 (30276)
2017 (27684)
2016 (27246)
2015 (32221)
2014 (25099)
2013 (22240)
2012 (22899)
2011 (23488)
2010 (21986)
Location
Africa (699)
Alabama (50)
Alaska (5)
Arizona (161)
Arkansas (10)
Asia (35528)
Australia (6238)
California (4861)
Canada (1687)
China (491)
Colorado (227)
Connecticut (246)
Delaware (143)
Europe (83758)
Florida (817)
Georgia (183)
Idaho (45)
Illinois (473)
India (25)
Indiana (288)
Iowa (7)
Japan (163)
Kansas (94)
Kentucky (18)
Louisiana (10)
Maine (34)
Maryland (817)
Massachusetts (3518)
Michigan (194)
Minnesota (337)
Mississippi (2)
Missouri (62)
Montana (29)
Nebraska (22)
Nevada (47)
New Hampshire (67)
New Jersey (1555)
New Mexico (27)
New York (1519)
North Carolina (868)
North Dakota (8)
Northern California (2153)
Ohio (188)
Oklahoma (7)
Oregon (27)
Pennsylvania (1135)
Puerto Rico (9)
Rhode Island (32)
South America (894)
South Carolina (25)
Southern California (1846)
Tennessee (91)
Texas (777)
United States (19285)
Utah (155)
Virginia (141)
Washington D.C. (59)
Washington State (460)
West Virginia (3)
Wisconsin (55)
579,851 Results for "uk medical research council mrc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
insitro and UK’s INSIGHT at Moorfields Eye Hospital Announce Collaboration to Expand Research Efforts in Neurodegeneration and Related Conditions
March 18, 2025
·
5 min read
Obesity
UK Pharmacies Regulator Wants Tighter Checks on Weight Loss Injections
Amid growing concern of the overuse and misuse of obesity drugs, the UK’s pharmacies regulator rolled out stricter guidelines for online pharmacies selling medicines including Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro.
February 4, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Oxford-Harrington Rare Disease Centre Appoints Majid Jafar to its Advisory Council
April 30, 2025
·
7 min read
Regulatory
Biogen, Eisai’s Leqembi Suffers Overseas Setbacks as UK Denies Coverage, Australia Denies Approval
Days after suffering a rejection in Australia, the Alzheimer’s drug hit another roadblock in the U.K., which found the drug not cost-effective.
March 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Fuse Oncology Establishes Clinical Liaison Council
March 10, 2025
·
2 min read
Press Releases
NanoPhoria Bioscience Awarded €17.5 M From European Innovation Council’s Accelerator Program
February 26, 2025
·
3 min read
Press Releases
Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center
February 19, 2025
·
2 min read
Press Releases
Cancer Research UK, Cytovation and the Norwegian Cancer Society collaborate to advance treatment for rare cancer
January 23, 2025
·
5 min read
Press Releases
Oxford-Harrington Rare Disease Centre Appoints Influential UK Leader in Health Innovation Policy, Baroness Nicola Blackwood, to its Advisory Council
September 11, 2024
·
5 min read
Press Releases
UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine
April 28, 2025
·
3 min read
1 of 57,986
Next
